Lista de obras -

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

artículo científico publicado en 2020

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR

article

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

scientific article published in Scientific Reports

ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis

scientific article published on 25 September 2020

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

artículo científico publicado en 2019

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

artículo científico publicado en 2020

Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma

article published in 2012

Association of Serum Adipocytokines With Insulin Resistance and Liver Injury in Patients With Chronic Hepatitis C Genotype 4 ⬇️

artículo científico publicado el 1 de noviembre de 2012

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4

artículo científico publicado el 1 de marzo de 2012

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C

artículo científico publicado el 1 de abril de 2011

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

artículo científico publicado en 2020

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

scientific article published on 04 June 2020

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

artículo científico publicado en 2016

FibroGENE: A gene-based model for staging liver fibrosis

artículo científico publicado en 2015

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

artículo científico publicado en 2018

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease

artículo científico publicado en 2020

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

artículo científico publicado en 2020

Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

artículo científico publicado en 2019

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

scientific article published on 11 December 2020

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

artículo científico publicado en 2017

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy

artículo científico publicado en 2010

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

artículo científico publicado en 2017

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

scientific article published on 16 October 2019

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

artículo científico publicado en 2014

Insulin resistance impairs viral dynamics independently of ethnicity or genotypes

artículo científico publicado en 2012

Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients

artículo científico publicado en 2010

Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection

artículo científico publicado en 2013

Interferon Lambda and Liver Fibrosis

scientific article published on 22 April 2019

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

artículo científico publicado en 2015

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B

artículo científico publicado en 2019

Liver Phenotypes of European Adults Heterozygous or Homozygous for PiZ Variant of AAT (PiMZ vs Pi*ZZ genotype) and Non-carriers

scientific article published on 03 May 2020

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

scientific article published on 30 September 2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

scientific article published on 07 February 2020

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

artículo científico publicado en 2016

Macrophages in metabolic associated fatty liver disease

scientific article published on 01 April 2020

Metabolic associated fatty liver disease and cancer risk: causal role or epiphenomenon?

scientific article published on 01 December 2020

Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis

artículo científico publicado en 2019

Patients with diabetes are at higher risk for severe illness from COVID-19

artículo científico publicado en 2020

Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

artículo científico publicado en 2009

Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans

artículo científico publicado en 2016

Redefining fatty liver disease: an international patient perspective

artículo científico publicado en 2020

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

artículo científico publicado en 2019

Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice

artículo científico publicado en 2020

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

artículo científico publicado en 2020

Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate

scientific article published on 12 September 2020

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

artículo científico publicado en 2020

Serum lipids and chronic hepatitis C genotype 4: interaction and significance ⬇️

artículo científico publicado el 1 de enero de 2012

TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.

artículo científico publicado en 2017

Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept ⬇️

artículo científico publicado el 1 de diciembre de 2011

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

artículo científico publicado en 2020

The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease

scientific article published on 28 March 2020

The changing epidemiology of liver diseases in the Asia-Pacific region

article

The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.

artículo científico publicado en 2017

The role of IFN in the development of NAFLD and NASH

article

The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.

artículo científico publicado en 2011

Toward More Accurate Nomenclature for Fatty Liver Diseases

scientific article published on 31 May 2019

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis

scientific article published on 07 May 2020

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective

scientific article published on 11 April 2020

When a new definition overhauls perceptions of MAFLD related cirrhosis care

scientific article published on 01 December 2020

Lista de obras de

A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma

Association of Serum Adipocytokines With Insulin Resistance and Liver Injury in Patients With Chronic Hepatitis C Genotype 4 ⬇️

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes

FibroGENE: A gene-based model for staging liver fibrosis

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease

GES: A validated simple score to predict risk of HCC in patients with HCV-GT4 associated advanced liver fibrosis after oral antivirals

Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology

Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

Insulin resistance impairs viral dynamics independently of ethnicity or genotypes

Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients

Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection

Interferon Lambda and Liver Fibrosis

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B

Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi*Z Variant of AAT (Pi*MZ vs Pi*ZZ genotype) and Non-carriers

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

Macrophages in metabolic associated fatty liver disease

Metabolic associated fatty liver disease and cancer risk: causal role or epiphenomenon?

Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis

Patients with diabetes are at higher risk for severe illness from COVID-19

Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans

Redefining fatty liver disease: an international patient perspective

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single-center cohort of European cirrhotics

Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Serum lipids and chronic hepatitis C genotype 4: interaction and significance ⬇️

TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.

Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept ⬇️

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease

The changing epidemiology of liver diseases in the Asia-Pacific region

The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.

The role of IFN in the development of NAFLD and NASH

The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.

Toward More Accurate Nomenclature for Fatty Liver Diseases

Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective

When a new definition overhauls perceptions of MAFLD related cirrhosis care

Liver Phenotypes of European Adults Heterozygous or Homozygous for PiZ Variant of AAT (PiMZ vs Pi*ZZ genotype) and Non-carriers